Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

PROPOXYPHENE - ANVISA Registration 10287411517

Access comprehensive regulatory information for PROPOXYPHENE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411517 and manufactured by ROCHE DIAGNOSTICS GMBH (MANNHEIM). The registration is held by ROCHE DIAGNร“STICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including SIEMENS HEALTHACARE DIAGNOSTICS INC, ROCHE DIAGNOSTICS GMBH, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
4 Competitors
4 Recent Registrations
10287411517
Registration Details
ANVISA Registration Number: 10287411517
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

PPX (ONLINE DAT Propoxyphene Plus)_cobas c
Risk Class II

Registration Details

10287411517

25351047607202056

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jul 20, 2020

VIGENTE

09/18/2025 19:00:01